Virios Therapeutics Inc.

13F holders, Q2 2024 (June 30)
24holders +4
7new positions
2sold out
$0.21avg. 13F price*

At the end of Q2 2024, 24 institutions reported holding Virios Therapeutics Inc. in their 13F filings, up 4 from Q1 2024. 7 opened new positions and 2 sold out. The largest holders were Vanguard Group Inc. ($45K), Geode Capital Management, LLC ($38K) and UBS Group AG ($33K).

Company
Virios Therapeutics Inc.
CUSIP
92829J104
Latest filing quarter
Q3 2024

History

Number of 13F holders

0510152025 Q1 2024: 20Q1 2024Q2 2024: 24Q2 2024Q3 2024: 24Q3 2024

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions7$60K
Exits2$8K

All 13F filers, Q1 2024 → Q2 2024: 334,655 shares bought and 24,145 shares sold, net +310,510 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 24 holders

Vanguard Group Inc. 0.00% No change 208,883 $45K
Geode Capital Management, LLC 0.00% No change 174,469 $38K
UBS Group AG 0.00% New 151,779 $33K
Susquehanna International Group, LLP 0.00% Add +182.5% 65,991 $14K
McCollum Christoferson Group LLC 0.00% Add +35.7% 57,000 $12K
HRT Financial LP 0.00% New 57,544 $12K
State Street Corp. 0.00% No change 52,828 $11K
XTX Topco Ltd 0.00% New 42,650 $9K
Raymond James & Associates 0.00% No change 30,000 $6K
Northern Trust Corp. 0.00% No change 24,035 $5K
Regions Financial Corp. 0.00% No change 20,072 $4K
Northwestern Mutual Wealth Management Co. 0.00% No change 19,062 $4K
Morgan Stanley 0.00% No change 15,000 $3K
Virtu Financial LLC 0.00% New 11,850 $3K
Cetera Investment Advisers 0.00% Reduce -1.6% 11,901 $3K
&partners 0.00% No change 11,000 $2K
One Plus One Wealth Management, LLC 0.00% New 10,000 $2K
William Howard & Co Financial Advisors Inc 0.00% No change 10,072 $2K
Tower Research Capital LLC (TRC) 0.00% Add +0.9% 6,876 $1K
Activest Wealth Management 0.00% New 3,000 $645
Group One Trading LLC 0.00% Reduce -84.0% 1,297 $279
BlackRock Inc. 0.00% No change 755 $162
Bank of America Corp. 0.00% New 139 $30
Royal Bank of Canada 0.00% No change 56 $0

"% of holder's portfolio" is VIRIOS THERAPEUTICS INC's weight in each manager's 13F, not the share of Virios Therapeutics Inc. the manager owns.